MarketReportsOnline.com adds "Global Breast Cancer Market Report: 2014 Edition" report to its research store.
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older.
In the past few years, the cases of breast cancer have increased tremendously in regions like the US and the Europe. The breast cancer market is driven by various factors like aging population in women, obesity and diabetes, hormonal factors, race and ethnicity and family history. A major trend which will probably remain eternally in the breast cancer treatment industry is the fact that novel and innovative technologies and pharmaceutical molecules are always under development. Challenges associated with breast cancer are like costs of treatment, regulatory measures and adverse effects of the treatment on patients.
Complete report available @ http://www.marketreportsonline.com/349683.html.
The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and agreements to develop effective treatment methods for breast cancer.
The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, India, China and Brazil. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include Hologic, Johnson and Johnson, Siemens AG, Roche and Novartis which are also profiled in this report.
Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=349683.
Table of Contents
1. Market Overview
1.1 Breast Cancer
1.2 Types of Breast Cancer
1.3 Risk Factors
1.4 Symptoms of Breast Cancer
1.5 Diagnosis and Treatment of Breast Cancer
1.5.1 Breast Cancer Screening and Diagnostic Measures
1.5.2 Breast Cancer Treatment
2. Breast Cancer Market
2.1 Global Market
Market Value
Market Segments
2.2 Breast Cancer Diagnostics Market
2.2.1 The US
2.2.2 Brazil
2.2.3 India
2.2.4 China
2.3 Breast Cancer Therapeutics Market
2.3.1 Regional Analysis
2.3.2 Metastatic Breast Cancer
The US
Europe
China
3. Market Dynamics
3.1 Industry Developments
3.1.1 Diagnostic Tests
3.1.2 New Drugs & Therapies
3.2 Growth Drivers
3.2.1 Increasing Prevalence of Cancer Cases
3.2.2 Increasing Use of Tobacco and Alcohol
3.2.3 Expanding Obese and Diabetes Population
3.2.4 Rising Demand for Better Healthcare Options
3.2.5 Growing Women Population (+45 Years)
3.2.6 Increased Spending on Medicines
3.2.7 Dense Breast Tissue
3.2.8 Race\Ethnicity
3.2.9 Exposure to Oestrogen
3.2.10 Hormonal Factors or HRT (Hormone Replacement Therapy)
3.2.11 Exposure to Radiation
3.3 Challenges
3.3.1 Rising Costs of Treatment
3.3.2 Stringent Regulatory Measures
3.3.3 Adverse Effects of the Treatment
3.3.4 Mounting Price Pressure
4. Competitive Landscape
Competitive Overview
Market Share
5. Company Profiles
5.1 Hologic, Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Focus on Research & Development
Business Expansion via Acquisitions
5.2 Johnson & Johnson
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Research and Development Activities
Strategic Acquisitions
5.3 F. Hoffmann-La Roche Ltd
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Accelerating R&D Activities
Building on Strength in Biotechnology
5.4 Novartis
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Focus on R&D Activities
Business Expansion via Acquisitions
5.5 Siemens AG
5.5.1 Business Overview
5.5.2 Financial Overview
5.5.3 Business Strategies
Optimum Allocation of R&D Resources
Focus on Healthcare Segment
List of Tables
Stages of Breast Cancer
New Cases of Breast Cancer and Estimated Deaths in the US (2014E)
The US Tomosynthesis Market Opportunity
NeuVax / E75 (nelipepimut) Estimated Sales – Breast Cancer Market Size Model (2017E-2020E)
The US MBC Market (in US$ Million) 2010-2015E
European MBC Market (in US$ Million) 2010-2015E
Metasite Breast and Menacalc Are Mechanistically Different From Existing Gene-Based Tests
Breast Cancer Drugs & Agents in Clinical Development
Number of Cancer Cases Worldwide (2012)
IARC and WCRF/AICR Evaluations of Breast Cancer Risk Factors
FDA Regulation of Medical Devices
Comparison of Adjuvant Chemotherapy Tests in Breast Cancer
J&J’s R&D Statistics (2012 & 2013)
List of Charts
Types of Breast Cancer
Various Biopsy Methods
Global Oncology Spending (2010-2014E)
Global Breast Cancer Market by Segments (2013E)
Global Breast Cancer Predictive Diagnostic and Drug Technologies (2010-2014E)
The US Breast Imaging Systems Market (2010-2014E)
The US Digital Mammography Market (2010-2013)
Brazil’s Breast Cancer Imaging Market (2010-2014E)
India’s Breast Screening Market (2010-2014E)
China’s Breast Screening Market (2010-2014E)
Global Breast Cancer Therapeutics Market (2010-2014E)
Breast Cancer Therapeutics Market by Region
The US Metastatic Breast Cancer Market Revenues (2010-2014E)
Chinese Metastatic Breast Cancer Market Revenues (2010-2014E)
Breast Cancer Drug Breakdown in China (2013E)
Different Types of Cancer Worldwide (2012)
Increasing Prevalence of Diabetes by Region (2000-2030E)
Global Female Population, +45 Years (2008-2014E)
Global Spending on Medicines (2007-2017E)
New Female Breast Cancer Cases and Deaths by Age, US, (2013)
Global Oncology Pharmaceuticals - Market Share (2013E)
Global Breast Cancer Diagnostics – Market Share (2013E)
Hologic’s Revenue Share by Business Segment (2013)
Hologic’s Revenues (2009-2013)
Johnson & Johnson’s Revenues (2009-2013)
F. Hoffmann-La Roche - Business Segments (2013)
Roche Revenues (2009-2013)
Novartis Business Segments (2013)
Novartis Revenues (2009-2013)
Siemens AG’s Revenue by Business Segments (2013)
Siemens AG’s Revenues & Net Income (2009-2012)
Explore more reports on Pharmaceuticals Market @ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Contact:
Mr. Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older.
In the past few years, the cases of breast cancer have increased tremendously in regions like the US and the Europe. The breast cancer market is driven by various factors like aging population in women, obesity and diabetes, hormonal factors, race and ethnicity and family history. A major trend which will probably remain eternally in the breast cancer treatment industry is the fact that novel and innovative technologies and pharmaceutical molecules are always under development. Challenges associated with breast cancer are like costs of treatment, regulatory measures and adverse effects of the treatment on patients.
Complete report available @ http://www.marketreportsonline.com/349683.html.
The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and agreements to develop effective treatment methods for breast cancer.
The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, India, China and Brazil. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include Hologic, Johnson and Johnson, Siemens AG, Roche and Novartis which are also profiled in this report.
Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=349683.
Table of Contents
1. Market Overview
1.1 Breast Cancer
1.2 Types of Breast Cancer
1.3 Risk Factors
1.4 Symptoms of Breast Cancer
1.5 Diagnosis and Treatment of Breast Cancer
1.5.1 Breast Cancer Screening and Diagnostic Measures
1.5.2 Breast Cancer Treatment
2. Breast Cancer Market
2.1 Global Market
Market Value
Market Segments
2.2 Breast Cancer Diagnostics Market
2.2.1 The US
2.2.2 Brazil
2.2.3 India
2.2.4 China
2.3 Breast Cancer Therapeutics Market
2.3.1 Regional Analysis
2.3.2 Metastatic Breast Cancer
The US
Europe
China
3. Market Dynamics
3.1 Industry Developments
3.1.1 Diagnostic Tests
3.1.2 New Drugs & Therapies
3.2 Growth Drivers
3.2.1 Increasing Prevalence of Cancer Cases
3.2.2 Increasing Use of Tobacco and Alcohol
3.2.3 Expanding Obese and Diabetes Population
3.2.4 Rising Demand for Better Healthcare Options
3.2.5 Growing Women Population (+45 Years)
3.2.6 Increased Spending on Medicines
3.2.7 Dense Breast Tissue
3.2.8 Race\Ethnicity
3.2.9 Exposure to Oestrogen
3.2.10 Hormonal Factors or HRT (Hormone Replacement Therapy)
3.2.11 Exposure to Radiation
3.3 Challenges
3.3.1 Rising Costs of Treatment
3.3.2 Stringent Regulatory Measures
3.3.3 Adverse Effects of the Treatment
3.3.4 Mounting Price Pressure
4. Competitive Landscape
Competitive Overview
Market Share
5. Company Profiles
5.1 Hologic, Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Focus on Research & Development
Business Expansion via Acquisitions
5.2 Johnson & Johnson
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Research and Development Activities
Strategic Acquisitions
5.3 F. Hoffmann-La Roche Ltd
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Accelerating R&D Activities
Building on Strength in Biotechnology
5.4 Novartis
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Focus on R&D Activities
Business Expansion via Acquisitions
5.5 Siemens AG
5.5.1 Business Overview
5.5.2 Financial Overview
5.5.3 Business Strategies
Optimum Allocation of R&D Resources
Focus on Healthcare Segment
List of Tables
Stages of Breast Cancer
New Cases of Breast Cancer and Estimated Deaths in the US (2014E)
The US Tomosynthesis Market Opportunity
NeuVax / E75 (nelipepimut) Estimated Sales – Breast Cancer Market Size Model (2017E-2020E)
The US MBC Market (in US$ Million) 2010-2015E
European MBC Market (in US$ Million) 2010-2015E
Metasite Breast and Menacalc Are Mechanistically Different From Existing Gene-Based Tests
Breast Cancer Drugs & Agents in Clinical Development
Number of Cancer Cases Worldwide (2012)
IARC and WCRF/AICR Evaluations of Breast Cancer Risk Factors
FDA Regulation of Medical Devices
Comparison of Adjuvant Chemotherapy Tests in Breast Cancer
J&J’s R&D Statistics (2012 & 2013)
List of Charts
Types of Breast Cancer
Various Biopsy Methods
Global Oncology Spending (2010-2014E)
Global Breast Cancer Market by Segments (2013E)
Global Breast Cancer Predictive Diagnostic and Drug Technologies (2010-2014E)
The US Breast Imaging Systems Market (2010-2014E)
The US Digital Mammography Market (2010-2013)
Brazil’s Breast Cancer Imaging Market (2010-2014E)
India’s Breast Screening Market (2010-2014E)
China’s Breast Screening Market (2010-2014E)
Global Breast Cancer Therapeutics Market (2010-2014E)
Breast Cancer Therapeutics Market by Region
The US Metastatic Breast Cancer Market Revenues (2010-2014E)
Chinese Metastatic Breast Cancer Market Revenues (2010-2014E)
Breast Cancer Drug Breakdown in China (2013E)
Different Types of Cancer Worldwide (2012)
Increasing Prevalence of Diabetes by Region (2000-2030E)
Global Female Population, +45 Years (2008-2014E)
Global Spending on Medicines (2007-2017E)
New Female Breast Cancer Cases and Deaths by Age, US, (2013)
Global Oncology Pharmaceuticals - Market Share (2013E)
Global Breast Cancer Diagnostics – Market Share (2013E)
Hologic’s Revenue Share by Business Segment (2013)
Hologic’s Revenues (2009-2013)
Johnson & Johnson’s Revenues (2009-2013)
F. Hoffmann-La Roche - Business Segments (2013)
Roche Revenues (2009-2013)
Novartis Business Segments (2013)
Novartis Revenues (2009-2013)
Siemens AG’s Revenue by Business Segments (2013)
Siemens AG’s Revenues & Net Income (2009-2012)
Explore more reports on Pharmaceuticals Market @ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Contact:
Mr. Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com
No comments:
Post a Comment